Anti-Wrinkle Efficacy of Cross-Linked Hyaluronic Acid-Based Microneedle Patch with Acetyl Hexapeptide-8 and Epidermal Growth Factor on Korean Skin
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Hyaluronic acid (HA)-based microneedle patch has recently been studied for wrinkle improvement. Cross-linked HA (CLHA) is widely used in dermal fillers. Acetyl hexapeptide-8 (AHP-8) and epidermal growth factor (EGF) are used for cosmetic ingredients. Objective: This study aimed to verify the efficacy of the CLHA/HA-based patch with microstructure (microneedle patch) containing AHP-8 or EGF. Methods: A total of 52 Korean females were enrolled in a double-blind, randomized, controlled, splitface trial. The subjects were divided into 3 groups: (1) microneedle patch alone, (2) microneedle patch/AHP-8, and (3) microneedle patch/EGF. The treatment was applied on the periorbital and nasolabial fold area for 4 hours to completely dissolve the microstructures once per week for 29 days. Evaluations, including photodamage scoring, image analysis with Antera 3DⓇ (Miravex, Ireland), skin hydration measurement, and adverse effect assessments, were performed at each visit. Results: Fifty subjects (96.2%) completed this clinical study. On day 29 after application, statistically significant improvements in wrinkle and skin hydration were observed in all groups (p<0.01). Treatment with microneedle patch/AHP-8 and microneedle patch/EGF showed statistically significant improvements in wrinkle compared with microneedle patch alone (p<0.05). No serious adverse effects were noted. Conclusion: Combination of CLHA-based microneedle patch and functional cosmetic ingredients can improve wrinkle with minimal discomfort.
Abstract
Background: Hyaluronic acid (HA)-based microneedle patch has recently been studied for wrinkle improvement. Cross-linked HA (CLHA) is widely used in dermal fillers. Acetyl hexapeptide-8 (AHP-8) and epidermal growth factor (EGF) are used for cosmetic ingredients. Objective: This study aimed to verify the efficacy of the CLHA/HA-based patch with microstructure (microneedle patch) containing AHP-8 or EGF. Methods: A total of 52 Korean females were enrolled in a double-blind, randomized, controlled, splitface trial. The subjects were divided into 3 groups: (1) microneedle patch alone, (2) microneedle patch/AHP-8, and (3) microneedle patch/EGF. The treatment was applied on the periorbital and nasolabial fold area for 4 hours to completely dissolve the microstructures once per week for 29 days. Evaluations, including photodamage scoring, image analysis with Antera 3DⓇ (Miravex, Ireland), skin hydration measurement, and adverse effect assessments, were performed at each visit. Results: Fifty subjects (96.2%) completed this clinical study. On day 29 after application, statistically significant improvements in wrinkle and skin hydration were observed in all groups (p<0.01). Treatment with microneedle patch/AHP-8 and microneedle patch/EGF showed statistically significant improvements in wrinkle compared with microneedle patch alone (p<0.05). No serious adverse effects were noted. Conclusion: Combination of CLHA-based microneedle patch and functional cosmetic ingredients can improve wrinkle with minimal discomfort.
참고문헌 (31)
- Papakonstantinou E, "Hyaluronic acid : a key molecule in skin aging", Dermatoendocrinol, 4, pp.253~258 (2012)
- Prestwich GD, "Controlled chemical modification of hyaluronic acid : synthesis, applications, and biodegradation of hydrazide derivatives", J Control Release, 53, pp.93~103 (1998)
- Bulpitt P, "New strategy for chemical modification of hyaluronic acid : preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels", J Biomed Mater Res, 47, pp.152~169 (1999)
- Al-Sibani M, "Evaluation of invitro degradation rate of hyaluronic acid-based hydrogel cross-linked with 1, 4-butanediol diglycidyl ether(BDDE)using RP-HPLC and UV-Vis spectroscopy", J Drug Deliv Sci Technol, 29, pp.24~30 (2015)
- Kenne L, "Modification and cross-linking parameters in hyaluronic acid hydrogels--definitions and analytical methods", Carbohydr Polym, 91, pp.410~418 (2013)
- Liu S, "Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin", Eur J Pharm Biopharm, 86, pp.267~276 (2014)
- Choi SY, "Hyaluronic acid microneedle patch for the improvement of crow's feet wrinkles", Dermatol Ther, 30, pp.e12546~ (2017)
- Kim M, "Novel cosmetic patches for wrinkle improvement : retinyl retinoate-and ascorbic acid-loaded dissolving microneedles", Int J Cosmet Sci, 36, pp.207~212 (2014)
- Lee C, "Evaluation of the anti-wrinkle effect of an ascorbic acidloaded dissolving microneedle patch via a double-blind, placebo-controlled clinical study", Int J Cosmet Sci, 38, pp.375~381 (2016)
- Hong JY, "Efficacy and safety of a novel, soluble microneedle patch for the improvement of facial wrinkle", J Cosmet Dermatol, 17, pp.235~241 (2018)
- Chung JH, "Cutaneous photodamage in Koreans : influence of sex, sun exposure, smoking, and skin color", Arch Dermatol, 137, pp.1043~1051 (2001)
- Larnier C, "Evaluation of cutaneous photodamage using a photographic scale", Br J Dermatol, 130, pp.167~173 (1994)
- Messaraa C, "Wrinkle and roughness measurement by the Antera 3D and its application for evaluation of cosmetic products", Skin Res Technol, 24, pp.359~366 (2018)
- Hamilton JD, "Fabrication and analysis of injection molded plastic microneedle arrays", pp.2010
- Weindl G, "Hyaluronic acid in the treatment and prevention of skin diseases : molecular biological, pharmaceutical and clinical aspects", Skin Pharmacol Physiol, 17, pp.207~213 (2004)
- Tammi MI, "Hyaluronan and homeostasis : a balancing act", J Biol Chem, 277, pp.4581~4584 (2002)
- Wang F, "In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin", Arch Dermatol, 143, pp.155~163 (2007)
- Shoshani D, "The modified Fitzpatrick Wrinkle Scale: a clinical validated measurement tool for nasolabial wrinkle severity assessment", Dermatol Surg, (34 Suppl 1), pp.S85~S91 (2008)
- Linming F, "Comparison of two skin imaging analysis instruments : the VISIA® from Canfield vs the ANTERA 3D® CS from Miravex", Skin Res Technol, 24, pp.3~8 (2018)
- Blanes-Mira C, "A synthetic hexapeptide(Argireline)with antiwrinkle activity", Int J Cosmet Sci, 24, pp.303~310 (2002)
- Wang Y, "The antiwrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects : a randomized, placebo-controlled study", Am J Clin Dermatol, 14, pp.147~153 (2013)
- Gutierrez LM, "A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells", J Biol Chem, 272, pp.2634~2639 (1997)
- Schouest JM, "Improved texture and appearance of human facial skin after daily topical application of barley produced, synthetic, human-like epidermal growth factor(EGF)serum", J Drugs Dermatol, 11, pp.613~620 (2012)
- An JJ, "Protective effects of skin permeable epidermal and fibroblast growth factor against ultraviolet-induced skin damage and human skin wrinkles", J Cosmet Dermatol, 12, pp.287~295 (2013)
- 박지훈, "생분해성 마이크로니들 패치(Biodegradable Microneedle Patch)를 이용한 눈가 주름의 개선에 관한 연구", 대한피부과학회지, 52(9), pp.597~607 (2014), 대한피부과학회
- 박선영, "Investigation of the Degradation-Retarding Effect Caused by the Low Swelling Capacity of a Novel Hyaluronic Acid Filler Developed by Solid-Phase Crosslinking Technology", Annals of Dermatology, 26(3), pp.357~362 (2014), 대한피부과학회
- Fraser JR, "Hyaluronan : its nature, distribution, functions and turnover", J Intern Med, 242, pp.27~33 (1997)
- De Boulle K, "A review of the metabolism of 1, 4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers", Dermatol Surg, 39, pp.1758~1766 (2013)
- Edsman K, "Gel properties of hyaluronic acid dermal fillers", Dermatol Surg, 38(7 Pt 2), pp.1170~1179 (2012)
- Kablik J, "Comparative physical properties of hyaluronic acid dermal fillers", Dermatol Surg, (35 Suppl 1), pp.302~312 (2009)
- Choi JT, "Microneedles containing crosslinked hyaluronic acid particulates for control of degradation and swelling behaviour after administration into skin", J Drug Target, 26, pp.884~894 (2018)
